Table 1.
Age, median (range), years | 67 (42–89) |
Gender: female, n (%) | 89 (66) |
BMI, median (range) | 29 (21–49) |
Subgroups of obesity, n (%), median BMI | |
< 30 | 71 (53), 26 |
30–35 | 42 (31), 33 |
≥ 35 | 21 (16), 38 |
Glucose metabolism, n (%) | |
Normal, | 68 (51) |
IFG/IGT | 32 (24) |
Diabetes | |
Previously diagnosed | 19 (14) |
Newly diagnosed | 15 (11) |
Metabolic syndrome, n (%) | 85 (63) |
Operated joint, n (%) | |
Hip | 54 (40) |
Knee | 80 (60) |
Bilateral operation, n | |
(% of hip/knee replacement patients) | |
Hip | 4 (7) |
Knee | 10 (13) |
Kellgren-Lawrence rating, n (%) | |
1 | 0 (0) |
2 | 24 (18) |
3 | 56 (42) |
4 | 51 (38) |
Earlier joint replacement, n (%) | 26 (19) |
ASA rating, n (%) | |
1 | 10 (8) |
2 | 65 (49) |
3 | 58 (43) |
4 | 1 (1) |
Smoker, n (%) | 12 (9) |
Preoperative pain, VAS, median (range)a | |
At rest | 39 (1–97) |
In motion | 81 (4–99) |
Duration of follow-up, median (range), months | 18 (11–28) |
IFG: increased fasting glucose;
IGT: impaired glucose tolerance;
VAS: visual analog scale (0–100)
a 82% (110/134) had filled in the VAS scale.